Actinomycetoma by Actinomadura madurae. Clinical and therapeutic characteristics of 18 cases with two treatment modalities
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2020.1793887
Abstract: Abstract Background Actinomycetoma due to Actinomadura madurae is susceptible to numerous chemotherapeutic agents, however, the response to those treatments is variable and closely related to several factors. Objective We aimed to evaluate the clinical-therapeutic characteristics… read more here.
Keywords: therapeutic characteristics; treatment modalities; treatment; actinomadura madurae ... See more keywords
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Antimicrobial Chemotherapy"
DOI: 10.1093/jac/dkac367
Abstract: Abstract Objectives Actinomycetoma is a chronic granulomatous disease affecting skin, subcutaneous tissue, fascia, muscle and bones. With increasing resistance against commonly used treatment regimens, susceptibility testing is urgently needed. Methods We developed an in vitro… read more here.
Keywords: vitro susceptibility; susceptibility testing; susceptibility; actinomadura madurae ... See more keywords
Keratinocyte infection by Actinomadura madurae triggers an inflammatory response.
Sign Up to like & getrecommendations! Published in 2019 at "Transactions of the Royal Society of Tropical Medicine and Hygiene"
DOI: 10.1093/trstmh/trz022
Abstract: BACKGROUND Actinomycetoma is a syndrome of the skin characterized by chronic inflammation and lesions with nodular grain-like structures. The most common aetiological agents are Nocardia brasiliensis and Actinomadura madurae. In response to infection with these… read more here.
Keywords: pro inflammatory; infection; response; actinomadura madurae ... See more keywords